Truist Financial Corp Sells 2,575 Shares of The Clorox Company (NYSE:CLX)

Truist Financial Corp lessened its stake in The Clorox Company (NYSE:CLX - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 33,729 shares of the company's stock after selling 2,575 shares during the quarter. Truist Financial Corp's holdings in Clorox were worth $5,478,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter valued at approximately $54,000. Los Angeles Capital Management LLC lifted its stake in Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock valued at $31,266,000 after acquiring an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. grew its position in Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC increased its stake in shares of Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock worth $10,341,000 after purchasing an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock valued at $117,932,000 after purchasing an additional 13,038 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have commented on CLX. JPMorgan Chase & Co. increased their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Barclays raised their price objective on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and increased their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Finally, Wells Fargo & Company upped their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $158.21.

Clorox Stock Performance

Clorox stock traded down $2.74 during trading hours on Monday, hitting $154.52. The stock had a trading volume of 1,693,548 shares, compared to its average volume of 1,363,494. The company has a 50-day moving average of $157.72 and a two-hundred day moving average of $159.96. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a market cap of $19.03 billion, a PE ratio of 42.22, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 earnings per share. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.